Cirrhosis epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
 
(41 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Cirrhosis}}
{{Cirrhosis}}
{{CMG}} {{AE}} {{ADI}} {{Cherry}}


{{CMG}} ; {{AE}} {{ADI}}
==Overview==
==Overview==
The most common cause of cirrhosis in the United States is chronic and heavy alcohol use, while the most common cause of cirrhosis worldwide is the [[hepatitis]] virus. Cirrhosis and [[chronic liver disease]] is the 12th leading cause of death in United States.
The most common cause of cirrhosis in the United States is chronic and heavy [[alcohol]] use, while the most common cause of cirrhosis worldwide and in Asian countries is the [[hepatitis]] virus. The gender that is most commonly affected by cirrhosis varies, depending upon the [[etiology]]. The [[incidence]] of cirrhosis increases with age; the median age of diagnosis of cirrhosis due to [[alcoholic liver disease]] is 52 years. The median age of diagnosis of cryptogenic/[[Non-alcoholic fatty liver disease|NAFLD]]/[[Non-alcoholic fatty liver disease|NASH]] cirrhosis is 60 years.


==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Prevalence===
===Prevalence===
* Cirrhosis and chronic liver disease were the 10th leading cause of death for men and the 12th for women in the United States in 2001, killing about 27,000 people each year.<ref>Anderson RN, Smith BL. Deaths: leading causes for 2001. ''Natl Vital Stat Rep''2003;52:1-85. PMID 14626726.</ref> Also, the cost of cirrhosis in terms of human suffering, hospital costs, and lost productivity is high.
* In 2015, the [[prevalence]] of cirrhosis was approximately 270 per 100,000 individuals in the United States.<ref name="pmid25291348">{{cite journal |vauthors=Scaglione S, Kliethermes S, Cao G, Shoham D, Durazo R, Luke A, Volk ML |title=The Epidemiology of Cirrhosis in the United States: A Population-based Study |journal=J. Clin. Gastroenterol. |volume=49 |issue=8 |pages=690–6 |year=2015 |pmid=25291348 |doi=10.1097/MCG.0000000000000208 |url=}}</ref>  
* Cirrhosis and chronic liver disease were the 12th leading cause of deaths in United States in 2006.<ref>Heron MP, Hoyert DL, Murphy SL, Xu JQ, Kochanek KD, Tejada-Vera B. Deaths: Final data for 2006. National vital statistics reports; vol 57 no 14. Hyattsville, MD: National Center for Health Statistics. 2009.</ref>
*Currently, approximately seventy percent of cirrhotic individuals are unaware of having [[liver]] disease and go undiagnosed.
* Established cirrhosis has a 10-year mortality of 34-66%, largely dependent on the cause of the cirrhosis; alcoholic cirrhosis has a worse prognosis than primary biliary cirrhosis and cirrhosis due to hepatitis. The risk of death due to all causes is increased twelvefold; if one excludes the direct consequences of the liver disease, there is still a fivefold increased risk of death in all disease categories.<ref>Sorensen HT, Thulstrup AM, Mellemkjar L, Jepsen P, Christensen E, Olsen JH, Vilstrup H. Long-term survival and cause-specific mortality in patients with cirrhosis of the liver: a nationwide cohort study in Denmark. ''J Clin Epidemiol''2003;56:88-93. PMID 12589875.</ref>
*The [[prevalence]] of cirrhosis is higher in:
* Hospital Inpatient Care:  Number of discharges with chronic liver disease or cirrhosis as the first-listed diagnosis: 101,000[http://www.cdc.gov/nchs/fastats/liverdis.htm]
**Non-Hispanic blacks
* Mortality due to cirrhosis and chronic liver disease in US:
**Individuals below the poverty line
** Number of deaths: 30,558
**Mexican Americans
** Deaths per 100,000 population: 10.0[http://www.cdc.gov/nchs/fastats/liverdis.htm]
**Areas with high illiteracy rates
* '''Alcoholic cirrhosis:''' Alcoholic cirrhosis develops in 15% of individuals who drink heavily for more than a decade.  There is great variability in the amount of alcohol needed to cause cirrhosis (as little as 3-4 drinks a day in some men and 2-3 in some women).
*Chronic and heavy [[alcohol]] use is responsible for more than half of the cases of cirrhosis in the United States.<ref name="pmid25291348">{{cite journal |vauthors=Scaglione S, Kliethermes S, Cao G, Shoham D, Durazo R, Luke A, Volk ML |title=The Epidemiology of Cirrhosis in the United States: A Population-based Study |journal=J. Clin. Gastroenterol. |volume=49 |issue=8 |pages=690–6 |year=2015 |pmid=25291348 |doi=10.1097/MCG.0000000000000208 |url=}}</ref>
* '''Chronic hepatitis B:''' The [[hepatitis B virus]] is probably the most common cause of cirrhosis worldwide, especially South-East Asia, but it is less common in the United States and the Western world.
*The cost of [[cirrhosis]] in terms of human suffering, hospital costs, and lost [[productivity]] is high.
* '''Primary biliary cirrhosis:''' In some areas of the US and UK the prevalence is estimated to be as high as 1 in 4000.
*The rate of developing [[hepatocellular carcinoma]] in cirrhotic patients is approximately 1%-4% per year.<ref name=":0">{{cite journal |author=Yu ML, Chuang WL |title=Treatment of chronic hepatitis C in Asia: when East meets West |journal=J. Gastroenterol. Hepatol. |volume=24 |issue=3 |pages=336–45 |year=2009 |pmid=19335784 |doi=10.1111/j.1440-1746.2009.05789.x |url=}},</ref>
* '''NASH:'''  NASH, in turn, may progress to [[fibrosis]] and, later, [[cirrhosis]]. Studies of serial liver biopsies estimate a 26-37% rate of hepatic fibrosis and 2-15% rate of cirrhosis in less than 6 years. <ref>Adams LA, Sanderson S, Lindor KD, et al. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 2005;42(1):132–8.</ref><ref>Harrison SA, Torgerson S, Hayashi PH. The natural history of nonalcoholic fatty liver disease:a clinical histopathological study. Am J Gastroenterol 2003;98(9):2042–7.</ref><ref>Ekstedt M, Franzén LE, Mathiesen UL, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006;44:865-73.</ref>
'''Alcoholic cirrhosis:'''  
* [[Cirrhosis|Alcoholic cirrhosis]] develops in 15% of individuals who drink heavily for more than a decade.   
* There is great variability in the amount of [[alcohol]] needed to cause cirrhosis (as little as 3-4 drinks a day in some men and 2-3 in some women).<ref name="urlIncidence rates of liver cirrhosis and related diseases in Baltimore and selected areas of the United States - ScienceDirect">{{cite web |url=https://www.sciencedirect.com/science/article/pii/0021968179901176 |title=Incidence rates of liver cirrhosis and related diseases in Baltimore and selected areas of the United States - ScienceDirect |format= |work= |accessdate=}}</ref>
'''Chronic hepatitis B:'''  
* Chronic [[hepatitis B]] is the most common cause of cirrhosis worldwide, especially South-East Asia, but is less common in the United States.
'''Primary biliary cirrhosis:'''
* In some areas of the US and UK, the [[prevalence]] is as high as 1 in 4000.
'''Non alcoholic fatty liver disease (NAFLD):'''  <ref>Adams LA, Sanderson S, Lindor KD, et al. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 2005;42(1):132–8.</ref><ref>Harrison SA, Torgerson S, Hayashi PH. The natural history of nonalcoholic fatty liver disease:a clinical histopathological study. Am J Gastroenterol 2003;98(9):2042–7.</ref><ref>Ekstedt M, Franzén LE, Mathiesen UL, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006;44:865-73.</ref>
* [[Non-alcoholic fatty liver disease|NAFLD]] has a 30 percent risk of [[fibrosis]]
* [[Non-alcoholic fatty liver disease|NAFLD]] has a 2-15% rate of cirrhosis in less than 6 years
'''Alpha 1-antitrypsin deficiency''': 
* Approximately 40 percent of adults with [[Zygosity|homozygosity]] of PIZZ have histologically significant [[liver]] injury and cirrhosis.<ref>{{cite journal |author=Bals R |title=Alpha-1-antitrypsin deficiency |journal=Best Pract Res Clin Gastroenterol |volume=24 |issue=5 |pages=629–33 |year=2010 |pmid=20955965 |doi=10.1016/j.bpg.2010.08.006 |url=}}</ref>
'''Hepatopulmonary syndrom'''<nowiki/>e:
* [[Hepatopulmonary syndrome]] has a prevalence of 4-47% in cirrhotic patients.
'''Portopulmonary hypertension''':
* The prevalence of [[portopulmonary hypertension]] is 2% in patients with cirrhosis.
'''Cirrhotic cardiomyopathy:'''
* The prevalence of cirrhotic [[cardiomyopathy]] is 50%  in cirrhotic patients.
===Case-fatality rate/Mortality rate===
*The 10 year-[[mortality rate]] of cirrhosis is approximately 34- 66 percent, largely dependent on the cause of cirrhosis.
In 2001, cirrhosis was the tenth leading cause of death among men and the twelfth leading cause of death among women in the United States.<ref>Anderson RN, Smith BL. Deaths: leading causes for 2001. ''Natl Vital Stat Rep''2003;52:1-85. PMID 14626726.</ref>
* In 2006, cirrhosis was the twelfth leading cause of all deaths in United States.<ref>Heron MP, Hoyert DL, Murphy SL, Xu JQ, Kochanek KD, Tejada-Vera B. Deaths: Final data for 2006. National vital statistics reports; vol 57 no 14. Hyattsville, MD: National Center for Health Statistics. 2009.</ref>
===Age===
*Cirrhosis is infrequently seen in young adults.
*The incidence of cirrhosis increases with age; the median age at diagnosis of cirrhosis due to [[alcoholic liver disease]] is 52 years.<ref name="pmid25203153">{{cite journal |vauthors=Sajja KC, Mohan DP, Rockey DC |title=Age and ethnicity in cirrhosis |journal=J. Investig. Med. |volume=62 |issue=7 |pages=920–6 |year=2014 |pmid=25203153 |pmc=4172494 |doi=10.1097/JIM.0000000000000106 |url=}}</ref>
*The median age of diagnosis of cryptogenic/[[Non-alcoholic fatty liver disease|NAFLD]]/[[Non-alcoholic fatty liver disease|NASH]] cirrhosis is 60 years.
*The median age of diagnosis of [[Autoimmune hepatitis|autoimmune]] cirrhosis is 43 years.


===Race===
*The [[prevalence]] of cirrhosis is higher in: [http://www.natap.org/2005/AASLD/aasld_29.htm]<ref name="pmid25203153">{{cite journal |vauthors=Sajja KC, Mohan DP, Rockey DC |title=Age and ethnicity in cirrhosis |journal=J. Investig. Med. |volume=62 |issue=7 |pages=920–6 |year=2014 |pmid=25203153 |pmc=4172494 |doi=10.1097/JIM.0000000000000106 |url=}}</ref>
**Non-Hispanic blacks
**Mexican Americans
**Hispanics with [[hepatitis C]] infection
===Gender===
===Gender===
* '''[[Primary biliary cirrhosis]]''' : It is more common in women.
*The gender that is most commonly affected by cirrhosis varies, depending on the underlying [[etiology]].
* '''Chronic [[Hetaitis C]]''': Among those chronically infected, the risk of cirrhosis after 20 years varies between studies but has been estimated at ~10%-15% for men and ~1-5% for women. The reason for this difference is not known. Once cirrhosis is established, the rate of developing  [[hepatocellular carcinoma]] is ~1%-4% per year<ref>{{cite journal |author=Yu ML, Chuang WL |title=Treatment of chronic hepatitis C in Asia: when East meets West |journal=J. Gastroenterol. Hepatol. |volume=24 |issue=3 |pages=336–45 |year=2009 |month=March |pmid=19335784 |doi=10.1111/j.1440-1746.2009.05789.x |url=}},</ref>
'''Primary biliary cirrhosis''':
* '''[[Non alcoholic fatty liver disease]]''': Non-alcoholic fatty liver disease is also more common among men than women in all age groups until age 60, where the prevalence between sex equalize. This is due to the protective nature of [[estrogen]].<ref name=Lobanova2009>{{cite journal|author=Lobanova YS, Scherbakov AM, Shatskaya VA, Evteev VA, Krasil’nikov MA|title=NF- kappaB suppression provokes the sensitization of hormone-resistant breast cancer cells to estrogen apoptosis|journal=Mol Cell Biochem|volume=324|year=2009}}</ref>
*[[Primary biliary cirrhosis]] is more common in women.
* '''[[Autoimmune hepatitis]]''': [[Autoimmune hepatitis]] usually occurs in women (70 %) between the ages of 15 and 40.
'''Chronic [[Hepatitis C]]''':  
* The risk of cirrhosis after 20 years is estimated to be approximately 10%-15% for men and 1-5% for women.<ref name=":0" />
'''Non alcoholic fatty liver disease''':  
* [[Non-alcoholic fatty liver disease]] is more common among men than women in all age groups until age 60.
* At 60 years of age, the prevalence of cirrhosis in males and females equalizes, due to absence of the protective nature of [[estrogen]].<ref name="Lobanova2009">{{cite journal|author=Lobanova YS, Scherbakov AM, Shatskaya VA, Evteev VA, Krasil’nikov MA|title=NF- kappaB suppression provokes the sensitization of hormone-resistant breast cancer cells to estrogen apoptosis|journal=Mol Cell Biochem|volume=324|year=2009}}</ref>
'''Autoimmune hepatitis''':
* [[Autoimmune hepatitis]] usually occurs in women in seventy percent of cases between the ages of 15 and 40.
'''Alpha1 antitrypsin deficiency''':
* Male gender and [[obesity]] may be risk factors for progression to advanced [[liver]] disease in adulthood among patients with severe [[Alpha 1-antitrypsin deficiency|AAT]] deficiency.<ref>{{cite journal |author=Bowlus CL, Willner I, Zern MA, ''et al.'' |title=Factors associated with advanced liver disease in adults with alpha1-antitrypsin deficiency |journal=Clin. Gastroenterol. Hepatol. |volume=3 |issue=4 |pages=390–6 |year=2005 |pmid=15822045 |doi= |url=}}</ref>
===Developed Countries===
* Chronic and heavy [[alcohol]] use is responsible for more than half of the cases of cirrhosis in the United States.
 
===Developing Countries===
* Chronic [[hepatitis B]] is the most common cause of cirrhosis worldwide, especially South-East Asia, but is less common in the United States.


==References==
==References==
{{reflist|2}}
{{reflist|2}}


[[Category:Gastroenterology]]
[[Category:Hepatology]]
[[Category:Disease]]


 
{{WS}}
{{WH}}
{{WH}}
{{WS}}

Latest revision as of 18:24, 27 December 2017

Cirrhosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cirrhosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Tertiary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case studies

Case #1

Cirrhosis epidemiology and demographics On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cirrhosis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cirrhosis epidemiology and demographics

CDC on Cirrhosis epidemiology and demographics

Cirrhosis epidemiology and demographics in the news

Blogs on Cirrhosis epidemiology and demographics

Directions to Hospitals Treating Cirrhosis

Risk calculators and risk factors for Cirrhosis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2] Sudarshana Datta, MD [3]

Overview

The most common cause of cirrhosis in the United States is chronic and heavy alcohol use, while the most common cause of cirrhosis worldwide and in Asian countries is the hepatitis virus. The gender that is most commonly affected by cirrhosis varies, depending upon the etiology. The incidence of cirrhosis increases with age; the median age of diagnosis of cirrhosis due to alcoholic liver disease is 52 years. The median age of diagnosis of cryptogenic/NAFLD/NASH cirrhosis is 60 years.

Epidemiology and Demographics

Prevalence

  • In 2015, the prevalence of cirrhosis was approximately 270 per 100,000 individuals in the United States.[1]
  • Currently, approximately seventy percent of cirrhotic individuals are unaware of having liver disease and go undiagnosed.
  • The prevalence of cirrhosis is higher in:
    • Non-Hispanic blacks
    • Individuals below the poverty line
    • Mexican Americans
    • Areas with high illiteracy rates
  • Chronic and heavy alcohol use is responsible for more than half of the cases of cirrhosis in the United States.[1]
  • The cost of cirrhosis in terms of human suffering, hospital costs, and lost productivity is high.
  • The rate of developing hepatocellular carcinoma in cirrhotic patients is approximately 1%-4% per year.[2]

Alcoholic cirrhosis:

  • Alcoholic cirrhosis develops in 15% of individuals who drink heavily for more than a decade.
  • There is great variability in the amount of alcohol needed to cause cirrhosis (as little as 3-4 drinks a day in some men and 2-3 in some women).[3]

Chronic hepatitis B:

  • Chronic hepatitis B is the most common cause of cirrhosis worldwide, especially South-East Asia, but is less common in the United States.

Primary biliary cirrhosis:

  • In some areas of the US and UK, the prevalence is as high as 1 in 4000.

Non alcoholic fatty liver disease (NAFLD): [4][5][6]

  • NAFLD has a 30 percent risk of fibrosis
  • NAFLD has a 2-15% rate of cirrhosis in less than 6 years

Alpha 1-antitrypsin deficiency:

  • Approximately 40 percent of adults with homozygosity of PIZZ have histologically significant liver injury and cirrhosis.[7]

Hepatopulmonary syndrome:

Portopulmonary hypertension:

Cirrhotic cardiomyopathy:

  • The prevalence of cirrhotic cardiomyopathy is 50% in cirrhotic patients.

Case-fatality rate/Mortality rate

  • The 10 year-mortality rate of cirrhosis is approximately 34- 66 percent, largely dependent on the cause of cirrhosis.

In 2001, cirrhosis was the tenth leading cause of death among men and the twelfth leading cause of death among women in the United States.[8]

  • In 2006, cirrhosis was the twelfth leading cause of all deaths in United States.[9]

Age

  • Cirrhosis is infrequently seen in young adults.
  • The incidence of cirrhosis increases with age; the median age at diagnosis of cirrhosis due to alcoholic liver disease is 52 years.[10]
  • The median age of diagnosis of cryptogenic/NAFLD/NASH cirrhosis is 60 years.
  • The median age of diagnosis of autoimmune cirrhosis is 43 years.

Race

Gender

  • The gender that is most commonly affected by cirrhosis varies, depending on the underlying etiology.

Primary biliary cirrhosis:

Chronic Hepatitis C:

  • The risk of cirrhosis after 20 years is estimated to be approximately 10%-15% for men and 1-5% for women.[2]

Non alcoholic fatty liver disease:

  • Non-alcoholic fatty liver disease is more common among men than women in all age groups until age 60.
  • At 60 years of age, the prevalence of cirrhosis in males and females equalizes, due to absence of the protective nature of estrogen.[11]

Autoimmune hepatitis:

  • Autoimmune hepatitis usually occurs in women in seventy percent of cases between the ages of 15 and 40.

Alpha1 antitrypsin deficiency:

  • Male gender and obesity may be risk factors for progression to advanced liver disease in adulthood among patients with severe AAT deficiency.[12]

Developed Countries

  • Chronic and heavy alcohol use is responsible for more than half of the cases of cirrhosis in the United States.

Developing Countries

  • Chronic hepatitis B is the most common cause of cirrhosis worldwide, especially South-East Asia, but is less common in the United States.

References

  1. ↑ 1.0 1.1 Scaglione S, Kliethermes S, Cao G, Shoham D, Durazo R, Luke A, Volk ML (2015). "The Epidemiology of Cirrhosis in the United States: A Population-based Study". J. Clin. Gastroenterol. 49 (8): 690–6. doi:10.1097/MCG.0000000000000208. PMID 25291348.
  2. ↑ 2.0 2.1 Yu ML, Chuang WL (2009). "Treatment of chronic hepatitis C in Asia: when East meets West". J. Gastroenterol. Hepatol. 24 (3): 336–45. doi:10.1111/j.1440-1746.2009.05789.x. PMID 19335784.,
  3. ↑ "Incidence rates of liver cirrhosis and related diseases in Baltimore and selected areas of the United States - ScienceDirect".
  4. ↑ Adams LA, Sanderson S, Lindor KD, et al. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 2005;42(1):132–8.
  5. ↑ Harrison SA, Torgerson S, Hayashi PH. The natural history of nonalcoholic fatty liver disease:a clinical histopathological study. Am J Gastroenterol 2003;98(9):2042–7.
  6. ↑ Ekstedt M, Franzén LE, Mathiesen UL, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006;44:865-73.
  7. ↑ Bals R (2010). "Alpha-1-antitrypsin deficiency". Best Pract Res Clin Gastroenterol. 24 (5): 629–33. doi:10.1016/j.bpg.2010.08.006. PMID 20955965.
  8. ↑ Anderson RN, Smith BL. Deaths: leading causes for 2001. Natl Vital Stat Rep2003;52:1-85. PMID 14626726.
  9. ↑ Heron MP, Hoyert DL, Murphy SL, Xu JQ, Kochanek KD, Tejada-Vera B. Deaths: Final data for 2006. National vital statistics reports; vol 57 no 14. Hyattsville, MD: National Center for Health Statistics. 2009.
  10. ↑ 10.0 10.1 Sajja KC, Mohan DP, Rockey DC (2014). "Age and ethnicity in cirrhosis". J. Investig. Med. 62 (7): 920–6. doi:10.1097/JIM.0000000000000106. PMC 4172494. PMID 25203153.
  11. ↑ Lobanova YS, Scherbakov AM, Shatskaya VA, Evteev VA, Krasil’nikov MA (2009). "NF- kappaB suppression provokes the sensitization of hormone-resistant breast cancer cells to estrogen apoptosis". Mol Cell Biochem. 324.
  12. ↑ Bowlus CL, Willner I, Zern MA; et al. (2005). "Factors associated with advanced liver disease in adults with alpha1-antitrypsin deficiency". Clin. Gastroenterol. Hepatol. 3 (4): 390–6. PMID 15822045.

Template:WS Template:WH

Retrieved from "https://www.wikidoc.org/index.php?title=Cirrhosis_epidemiology_and_demographics&oldid=1425186"